Claudia de la Cruz
Dermacross(CL)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Health Systems, Economic Evaluations, Quality of Life, Asthma and respiratory diseases, COVID-19 Clinical Research Studies
Most-Cited Works
- → Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study(2020)158 cited
- → Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19(2021)115 cited
- → Psoriasis Following Bariatric Surgery: Clinical Evolution and Impact on Quality of Life on 10 patients(2012)74 cited
- → Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis(2016)65 cited
- → Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice(2017)52 cited
- Does maternal obesity cause preeclampsia? A systematic review of the evidence.(2012)
- → International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis Council(2024)48 cited
- → Risk‐mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey*(2020)33 cited
- → International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis(2022)23 cited
- → Topical photodynamic therapy with methylaminolevulinate for the treatment of actinic keratosis and reduction of photodamage in organ transplant recipients: A case-series of 16 patients(2012)18 cited